This event is archived. Final snapshot from when the story concluded. View on Dashboard
Events / Technology / Google Pixel Watch 3 FDA Clearance
Tech medical feature

Google Pixel Watch 3 FDA Clearance

Analysis based on 8 articles · First reported Feb 26, 2025 · Last updated Feb 28, 2025

Sentiment
60
Attention
4
Articles
8
Market Impact
General
Live prominence charts, article sentiment distribution, and event development timeline available on the Ergen Dashboard
Market Impact

The introduction of the Loss of Pulse Detection feature on the Pixel Watch 3 is expected to boost Alphabet Inc.'s competitiveness in the smartwatch market, potentially increasing sales and market share. This innovation could also set a new standard for health and safety features in wearable technology, influencing other companies like Apple Inc. to develop similar functionalities.

Consumer electronics Healthcare Technology
Event Summary

Alphabet Inc. has received United States — Food and Drug Administration clearance for its new Loss of Pulse Detection feature for the Pixel Watch 3. This first-of-its-kind feature, developed with cardiologists and emergency medical service leaders, uses an AI algorithm to detect when a user's heart stops beating due to events like cardiac arrest or poisoning. If no pulse or motion is detected and the user is unresponsive, the Pixel Watch 3 will automatically call emergency services and share the user's location. The feature is set to roll out in the United States by the end of March, having already been available in 14 other countries since September 2024. This advancement positions Alphabet Inc.'s Pixel Watch 3 with a significant safety advantage over competitors like the Apple Inc..

Key Actions
100 Alphabet Inc. received clearance United States — Food and Drug Administration
90 Alphabet Inc. developed feature
85 Pixel Watch 3 will offer detection
Entities Involved
oth
Pixel Watch 3
The Pixel Watch 3 is the device receiving the new Loss of Pulse Detection feature, which is expected to increase its value proposition in the smartwatch market.
Importance 90.0 Sentiment 60.0
per
Sandeep Waraich
Sandeep Waraich, senior director of product management for Pixel wearables at Alphabet Inc., provided insights into the development of the pulse detection feature.
Importance 20.0 Sentiment 0.0
govactor
United States — Food and Drug Administration
Importance 0.0 Sentiment 0.0
stock
Alphabet Inc.
Importance 0.0 Sentiment 0.0
cnt
United States
Importance 0.0 Sentiment 0.0
stock
Apple Inc.
Importance 0.0 Sentiment 0.0
Relationships
United States — Food and Drug Administration related ↔ United States
United States — Food and Drug Administration related ↔ Apple Inc.
Alphabet Inc. related ↔ United States
Alphabet Inc. AI partner ↔ Apple Inc. Alphabet licenses its Gemini AI models to Apple for integration into iOS and Apple Intelligence features, and pays Apple
United States related ↔ Apple Inc.
ERGEN INTELLIGENCE
Track this event live

Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.